Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 68382-522

5 FDA label images from Zydus Pharmaceuticals (usa) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 68382-522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (880b042a A73d 4032 92d1 E3d1c5f3c97e 01)

Image (880b042a A73d 4032 92d1 E3d1c5f3c97e 01)
Chemical structure of Propafenone Hydrochloride, showing its molecular arrangement including aromatic rings and various functional groups consistent with the compound's formula.*
FDA Label Image

Image (880b042a A73d 4032 92d1 E3d1c5f3c97e 02)

Image (880b042a A73d 4032 92d1 E3d1c5f3c97e 02)
A Kaplan-Meier curve chart depicting the proportion of patients without event over time (days) for Propafenone Hydrochloride extended release (ER) capsules at 225 mg, 325 mg, and 425 mg twice daily (bid) compared to placebo. The graph shows event-free proportions for each group up to 300 days, with patient numbers at risk listed at intervals. Statistical significance values (p-values) are indicated for different doses at week 39.*
FDA Label Image

Label (880b042a A73d 4032 92d1 E3d1c5f3c97e 03)

Label (880b042a A73d 4032 92d1 E3d1c5f3c97e 03)
Label for Propafenone Hydrochloride Extended-release Capsules, USP 225 mg by Zydus Pharmaceuticals (USA) Inc. The label shows NDC 68382-522-14, package size of 60 capsules, and identifies the product as prescription only. It includes storage instructions, child-resistant packaging notice, and manufacturer details from Zydus Lifesciences Ltd., India.*
FDA Label Image

Label (880b042a A73d 4032 92d1 E3d1c5f3c97e 04)

Label (880b042a A73d 4032 92d1 E3d1c5f3c97e 04)
Label for Propafenone Hydrochloride Extended-release Capsules, USP 325 mg, oral dosage form, by Zydus Pharmaceuticals (USA) Inc. The label identifies the product with NDC 68382-523-14, contains 60 capsules, and states Rx only. It includes storage instructions, handling warnings, manufacturer and distributor information, with a purple highlight behind the strength.*
FDA Label Image

Label (880b042a A73d 4032 92d1 E3d1c5f3c97e 05)

Label (880b042a A73d 4032 92d1 E3d1c5f3c97e 05)
Label for Propafenone Hydrochloride Extended-release Capsules, USP 425 mg by Zydus Pharmaceuticals (USA) Inc. The label indicates a package of 60 capsules, Rx only. It includes storage instructions, child-resistant packaging notice, manufacturing by Zydus Lifesciences Ltd., India, and distribution by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.